-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D/fr4NQe/Y0/9I1PCMyLJ2oH8Ppr6iq6kQJnMPwyUxnwk31HAaO29jE2JTuAYhCo w/nDoZKOE96ZcrlUrbwMDw== 0000950136-05-005095.txt : 20050817 0000950136-05-005095.hdr.sgml : 20050817 20050817155823 ACCESSION NUMBER: 0000950136-05-005095 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050817 DATE AS OF CHANGE: 20050817 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ORTHOMETRIX INC CENTRAL INDEX KEY: 0000946428 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 061387931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-45017 FILM NUMBER: 051033498 BUSINESS ADDRESS: STREET 1: 106 CORPORATE PARK DRIVE STREET 2: SUITE 106 CITY: WHITE PLAINS STATE: NY ZIP: 10604 BUSINESS PHONE: 9146942285 MAIL ADDRESS: STREET 1: 106 CORPORATE PARK DRIVE STREET 2: SUITE 106 CITY: WHITE PLAINS STATE: NY ZIP: 10604 FORMER COMPANY: FORMER CONFORMED NAME: NORLAND MEDICAL SYSTEMS INC DATE OF NAME CHANGE: 19951115 FORMER COMPANY: FORMER CONFORMED NAME: OSTECH INC DATE OF NAME CHANGE: 19950608 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BONMATI REYNALD G CENTRAL INDEX KEY: 0001006017 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: PREMIUM POINT CITY: NEW ROCHELLE STATE: NY ZIP: 10801 SC 13D/A 1 file001.htm AMENDMENT NO. 12 TO SCHEDULE 13D




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                 SCHEDULE 13D/A

                    Under the Securities Exchange Act of 1934
                               (Amendment No. 12)

                                ORTHOMETRIX, INC.
                                (Name of Issuer)

                         Common Stock, $.0005 par value
                         (Title of Class of Securities)

                                   68750M-10-0
                                 (CUSIP Number)

                               Reynald G. Bonmati
                                  Premium Point
                             New Rochelle, NY 10801
                                 (914) 576-1595

                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                 August 15, 2005
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-2(g), check the
following box [ ].

Note: Schedules filed in paper format shall include a signed original and five
copies of this schedule, including all exhibits, should be filed with the
Commission. See ss.240.13d-7(b) for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a person's initial
filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter disclosures
provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
"filed" for the purpose of Section 18 of the Securities Exchange Act of 1934
("Act") or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).






                                    SCHEDULE 13D

- --------------------------------------------------------------------------------
 1     NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
       (ENTITIES ONLY)

       REYNALD G. BONMATI

- --------------------------------------------------------------------------------
 2     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
       (a) ( )
       (b) (X)
- --------------------------------------------------------------------------------
 3     SEC USE ONLY

- --------------------------------------------------------------------------------
 4     SOURCE OF FUNDS (SEE INSTRUCTIONS)

       00

- --------------------------------------------------------------------------------
 5     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
       ITEMS 2(d) or 2(e) (  )
- --------------------------------------------------------------------------------
 6     CITIZENSHIP OR PLACE OF ORGANIZATION

       U.S. CITIZEN
- --------------------------------------------------------------------------------
 7                           SOLE VOTING POWER

NUMBER OF
SHARES
BENEFICIALLY                 6,803,420
OWNED BY EACH
REPORTING
PERSON WITH
- --------------------------------------------------------------------------------
 8                           SHARED VOTING POWER

                             13,359,499

- --------------------------------------------------------------------------------
 9                           SOLE DISPOSITIVE POWER

                             6,803,420

- --------------------------------------------------------------------------------
10                           SHARED DISPOSITIVE POWER

                             13,359,499
- --------------------------------------------------------------------------------
11     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

       21,332,850
- --------------------------------------------------------------------------------
12     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
       (SEE INSTRUCTIONS) (  )
- --------------------------------------------------------------------------------
13     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

       48.9%
- --------------------------------------------------------------------------------
14     TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

       IN
- --------------------------------------------------------------------------------






                           Statement on Schedule 13D/A

     This Amendment amends the Statement on Schedule 13D of the undersigned
filed with the Securities and Exchange Commission on August 4, 2000 (the
"Original Statement") with respect to the beneficial ownership by such person of
shares of common stock, $.0005 par value ("Common Stock"), of Orthometrix, Inc.,
a Delaware corporation (the "Issuer"). The filing of this Amendment is
occasioned by an exercise of stock options for Common Stock of the Issuer by
Bones, LLC, of which Mr. Bonmati is a managing member. Except as set forth
herein, the information provided in the original statement is unchanged.


ITEM 1.  SECURITY AND ISSUER.

     This statement relates to the Common Stock of the Issuer, Orthometrix, Inc.
The principal executive office of the Issuer is located at 106 Corporate Park
Drive, Suite 102, White Plains, New York 10604.

ITEM 2.  IDENTITY AND BACKGROUND.

     The person filing this statement is Reynald G. Bonmati, whose residence
address is Premium Point, New Rochelle, New York 10801. The undersigned is
Chairman of the Board, President, Treasurer and a Director of the Company. The
undersigned is also a managing member of Bones, LLC an entity which is a
stockholder of the Issuer.

     During the past five years, the foregoing party, has not (a) been convicted
in a criminal proceeding (excluding traffic violations or similar misdemeanors),
or (b) been party to a civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws, or finding
any violations with respect to such laws.

ITEM 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

     Bones, LLC, of which Mr. Bonmati is a managing member, exercised stock
options in the amount of $102,000 for its purchase of 680,000 shares of Common
Stock of the Issuer on August 15, 2005.

ITEM 4.  PURPOSE OF TRANSACTION.

     This Amendment is being filed as a result of the transactions described
above. The reporting persons have no present plans or proposals that relate to
or would result in or cause:





     (a)   the acquisition by any person of additional securities of the Issuer,
           or the disposition of securities of the Issuer;

     (b)   an extraordinary corporate transaction, such as a merger,
           reorganization or liquidation, involving the Issuer or any of its
           subsidiaries;

     (c)   a sale or transfer of a material amount of assets of the Issuer or
           any of its subsidiaries;

     (d)   any change in the present board of directors or management of the
           Issuer, including any plans or proposals to change the number or term
           of directors or to fill any existing vacancies on the board;

     (e)   any material change in the present capitalization or dividend policy
           of the Issuer;

     (f)   any other material change in the Issuer's business or corporate
           structure;

     (g)   changes in the Issuer's charter, bylaws or instruments corresponding
           thereto or other actions which may impede the acquisition of control
           of the Issuer by any person;

     (h)   a class of securities of the Issuer being de-listed from a national
           securities exchange or to cease to be authorized to be quoted in an
           interdealer quotation system of a registered national securities
           association;

     (i)   a class of equity securities of the Issuer becoming eligible for
           termination of registration pursuant to Section 12(g)(4)of the
           Securities Exchange Act of 1934; or

     (j)   any action similar to any of those enumerated above.

     The filing person reserves the right to adopt such plans and proposals
subject to applicable regulatory requirements, if any; and to transfer
securities of the Issuer directly and/or sell securities of the Issuer in the
open market.

ITEM 5.  INTEREST IN SECURITIES OF THE ISSUER.

     (a)   As of August 15, 2005, there were 43,657,368 shares of Common Stock
           of the Issuer outstanding. Mr. Bonmati may be deemed to be the
           beneficial owner of 21,332,850 shares of Common Stock (or 48.9% of
           the total shares outstanding). This figure includes: (i) 6,803,420
           shares owned directly by Mr. Bonmati; and (ii) 13,359,499 shares
           owned directly by Bones, LLC and indirectly by Mr. Bonmati.





           Mr. Bonmati may be deemed to beneficially own the shares owned by
           Bones LLC due to his relationship with such entity. Mr. Bonmati is a
           managing member of Bones LLC. Beneficial ownership of the stock owned
           by Bones is disclaimed by Mr. Bonmati, except to the extent of his
           proportionate interest in such entities. Mr. Bonmati disclaims
           beneficial ownership for 1,169,931 shares of Common Stock; of which
           1,159,931 shares are owned by Mr. Bonmati's wife, as trustee of the
           Sandrine Bonmati Trust and The Chrystele Bonmati Trust benefiting
           their children, and 10,000 shares are owned by Mr. Bonmati's
           granddaughter.

     (b)   Mr. Bonmati has sole power to vote and dispose of 6,803,420 shares
           owned directly by Mr. Bonmati and shared power to vote and dispose of
           13,359,499 shares owned by Bones LLC.

     (c)   There have been no transactions in securities of the Company affected
           during the past sixty days by the undersigned other than as described
           herein.

     (d)   Except as set forth in this Amended Statement, no other person is
           known to have the right to receive or the power to direct the receipt
           of dividends from, or the proceeds from the sale of, the securities
           of, the Issuer that are owned beneficially by the reporting persons.

     (e)   Item 5(e) is not applicable to this Amended Statement.


ITEM 6.    CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
           TO THE SECURITIES OF THE COMPANY

                       N/A

ITEM 7.    MATERIAL TO BE FILED AS EXHIBITS.

                       N/A








                                   SIGNATURES


     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.


Date:       August 17, 2005





                                                      /s/ Reynald G. Bonmati
                                                      --------------------------
                                                      Reynald G. Bonmati
                                                      President and Chairman

-----END PRIVACY-ENHANCED MESSAGE-----